Knema

Knema

This medicine is prescription only medicine (POM ) and it is required under medical supervision .

ဤဆေးသည် POM ဆေးအုပ်စုတွင်ပါဝင်သောကြောင့် ဆရာဝန်ညွှန်ကြားချက်အတိုင်းသာ သုံးစွဲသင့်ပါသည် ။

Description

Inhibition of lipid peroxidation by free radicals
Inhibition of liver cell breakdown
Inhibition of covalent binding with hepatotoxic substances  which are toxic  to lipids of microsomes by stabilizing  its membrane

Indication
    Treatment of chronic persisting and active hepatitis B
    Liver cirrhosis
    Drug-induced hepatitis associated with high SGPT Level

Dosage
    Generally, for adult one tablet three times daily.
    If the SGPT is not reduced to normal after administration of KNEMA for 1-2 months, the dose should be increased to 2 tablets three times daily.
    The course of treatment is at least 6 months and one year ( or ) dosage directed by the physician